234 related articles for article (PubMed ID: 19998154)
1. The duty to disclose adverse clinical trial results.
Liao SM; Sheehan M; Clarke S
Am J Bioeth; 2009 Aug; 9(8):24-32. PubMed ID: 19998154
[TBL] [Abstract][Full Text] [Related]
2. The duty to disclose (even more) adverse clinical trial results.
Hassoun N
Am J Bioeth; 2009 Aug; 9(8):33-4. PubMed ID: 19998155
[No Abstract] [Full Text] [Related]
3. Disclosing clinical trial results: publicity, significance and independence.
Liao SM; Sheehan M; Clarke S
Am J Bioeth; 2009 Aug; 9(8):W3-5. PubMed ID: 19998144
[No Abstract] [Full Text] [Related]
4. Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?
Vernillo A
Am J Bioeth; 2009 Aug; 9(8):45-7. PubMed ID: 19998162
[No Abstract] [Full Text] [Related]
5. Respecting participant autonomy and the disclosure of clinical trial results.
Oakley J
Am J Bioeth; 2009 Aug; 9(8):38. PubMed ID: 19998158
[No Abstract] [Full Text] [Related]
6. Compounding risks to patients: selective disclosure is not an option.
McGoey L
Am J Bioeth; 2009 Aug; 9(8):35-6. PubMed ID: 19998156
[No Abstract] [Full Text] [Related]
7. Improving subject recruitment by maintaining truly informed consent: a practical benefit of disclosing adverse clinical trial results.
Shah KR; Batzer FR
Am J Bioeth; 2009 Aug; 9(8):36-7. PubMed ID: 19998157
[No Abstract] [Full Text] [Related]
8. Precautionary harm disclosure in clinical trials.
Wu KC
Am J Bioeth; 2009 Aug; 9(8):43-5. PubMed ID: 19998161
[No Abstract] [Full Text] [Related]
9. The duty to register phase I trials.
Saunders PT
Am J Bioeth; 2009 Aug; 9(8):41-2. PubMed ID: 19998160
[No Abstract] [Full Text] [Related]
10. The ethics of disclosing to research subjects the availability of off-label marketed drugs.
Taylor HA; Kuwana E; Wilfond BS
Am J Bioeth; 2014; 14(4):51. PubMed ID: 24730496
[No Abstract] [Full Text] [Related]
11. Response to the open peer commentaries on "Is there an ethical obligation to disclose controversial risk? A question from the ACCORD Trial".
DeMarco JP; Ford PJ; Patton DJ; Stewart DO
Am J Bioeth; 2014; 14(4):W1-2. PubMed ID: 24730505
[No Abstract] [Full Text] [Related]
12. Researchers have an ethical obligation to disclose the availability of off-label marketed drugs.
Silber TJ
Am J Bioeth; 2014; 14(4):52. PubMed ID: 24730497
[No Abstract] [Full Text] [Related]
13. A duty to deceive: placebos in clinical practice.
Foddy B
Am J Bioeth; 2009 Dec; 9(12):4-12. PubMed ID: 20013484
[TBL] [Abstract][Full Text] [Related]
14. Which alternatives should investigators disclose to research subjects?
Phillips J; Wendler D
Am J Bioeth; 2014; 14(4):54-5. PubMed ID: 24730499
[No Abstract] [Full Text] [Related]
15. Disclosing conflicts of interest to research subjects: an ethical and legal analysis.
Resnik DB
Account Res; 2004; 11(2):141-59. PubMed ID: 15675055
[TBL] [Abstract][Full Text] [Related]
16. The ethical imperative of risk disclosure in research: the answer is always yes.
Quinn GP; Haura EB; Murphy D
Am J Bioeth; 2014; 14(4):18-9. PubMed ID: 24730484
[No Abstract] [Full Text] [Related]
17. Obligations in offering to disclose genetic research results.
Fernandez CV; Weijer C
Am J Bioeth; 2006; 6(6):44-6; author reply W10-2. PubMed ID: 17085409
[No Abstract] [Full Text] [Related]
18. Taking our obligations to research participants seriously: disclosing individual results of genetic research.
Manolio TA
Am J Bioeth; 2006; 6(6):32-4; author reply W10-2. PubMed ID: 17085403
[No Abstract] [Full Text] [Related]
19. Enhancing informed consent in clinical trials and exploring resistances to disclosing adverse clinical trial results.
Banja JD; Dunlop B
Am J Bioeth; 2009 Aug; 9(8):39-41. PubMed ID: 19998159
[No Abstract] [Full Text] [Related]
20. The role of the clinical trial nurse in the informed consent process.
Cantini F; Ells C
Can J Nurs Res; 2007 Jun; 39(2):126-44. PubMed ID: 17679589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
